Citations 83

[O1–12–02]: PROGRESSION FROM PRECLINICAL AD TO MCI OVER A DECADE: COGNITIVE AND BRAIN IMAGING TRAJECTORIES

Alzheimer's & Dementia | October 20, 2017 | Volume: 13 | Issue: 7S_Part_4 | Pages: No page available

10.1016/j.jalz.2017.07.102

P1‐325: Predicting Progression to Mild Cognitive Impairment in Cognitively Unimpaired Individuals Using Neuroimaging Biomarkers

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_11 | Pages: No page available

10.1016/j.jalz.2016.06.1076

P2‐243: Higher BMI is Associated with Greater Cerebral Glucose Metabolism in Late Middle‐Aged and Elderly Subjects Regardless of APOE ε4 Genotype

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_14 | Pages: No page available

10.1016/j.jalz.2016.06.1411

P4‐149: Peripheral Apoe Levels are Associated with Regional Gray Matter Volume, Cerebral Glucose Metabolism and Cognitive Performance in Cognitively Normal APOE E3/4 Carriers

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_22 | Pages: No page available

10.1016/j.jalz.2016.06.2240

P3‐285: Patch‐Based Sparse Coding and Multivariate Surface Morphometry for Predicting Amnestic Mild Cognitive Impairment and Alzheimer’S Disease in Cognitively Unimpaired Individuals

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_19 | Pages: No page available

10.1016/j.jalz.2016.06.1939

P3‐169: Reduced default network functional connectivity and verbal learning in cognitively unimpaired late middle‐aged and older adults: Exploratory findings from the arizona ApoE cohort study

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_15 | Pages: No page available

10.1016/j.jalz.2015.06.1540

P4‐053: Memory, executive, and multi‐domain subtle cognitive impairment: Clinical and biomarker finding

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_17 | Pages: No page available

10.1016/j.jalz.2015.06.1758

Memory, executive, and multidomain subtle cognitive impairment

Neurology | June 18, 2015 | Volume: 85 | Issue: 2 | Pages: 144-153

10.1212/wnl.0000000000001738 | PMID 26085606

Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures

Neurology | January 22, 2015 | Volume: 84 | Issue: 7 | Pages: 729-737

10.1212/wnl.0000000000001231 | PMID 25609767

P4‐298: IMPROVING THE POWER TO TRACK FIBRILLAR AMYLOID PET MEASUREMENTS AND EVALUATE AMYLOID‐MODIFYING TREATMENTS USING A CEREBRAL WHITE MATTER REFERENCE REGION‐OF‐INTEREST

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_15 | Pages: No page available

10.1016/j.jalz.2014.07.069